An investigational drug is being tried on healthy volunteers for its safety and pharmacokinetic properties. Which of the following stages in the drug development process does this scenario most closely describe?
Select Your Answer:
Phase I trials aim to understand the safety and pharmacokinetic properties of an investigational drug.
Phase II trials aim to evaluate the efficacy of the a drug on small number of patients.
Phase III trials are done on a large number of patients to compare the efficacy of the new drug to that of a standard therapy or placebo.
*eMedicine, Google Scholar, UpToDate, WheelessOnline, and DermNet are not affiliated with StatPearls. We do not control their content or advertising.
Adult Lab Normals
Pediatric Lab Normals
From molecules to medicines: the dawn of targeted therapies for genetic epilepsies., Demarest ST,Brooks-Kayal A,, Nature reviews. Neurology, 2018 Nov 17 [PubMed PMID: 30448857]
Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients: Potential for drug-drug interactions., Riess H,Prandoni P,Harder S,Kreher S,Bauersachs R,, Critical reviews in oncology/hematology, 2018 Dec [PubMed PMID: 30447923]
Novel Pharmacotherapy for Hypertrophic Cardiomyopathy., Wong TC,Martinez M,, Cardiology clinics, 2019 Feb [PubMed PMID: 30447712]
A randomized controlled trial and economic evaluation of the Parents Under Pressure program for parents in substance abuse treatment., Barlow J,Sembi S,Parsons H,Kim S,Petrou S,Harnett P,Dawe S,, Drug and alcohol dependence, 2018 Nov 3 [PubMed PMID: 30447510]
Targeting the Proteasome in Refractory Pediatric Leukemia Cells: Characterization of Effective Cytotoxicity of Carfilzomib., Swift L,Jayanthan A,Ruan Y,Anderson R,Boklan J,Trippett T,Narendran A,, Targeted oncology, 2018 Nov 16 [PubMed PMID: 30446871]